4.8 Article Retracted Publication

被撤回的出版物: Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer(Retracted article. See vol. 7, pg. 561, 2017)

期刊

THERANOSTICS
卷 1, 期 -, 页码 3-17

出版社

IVYSPRING INT PUBL
DOI: 10.7150/thno/v01p0003

关键词

Plasmonic nanobubble; gold nanoparticle; laser; photothermal; prostate cancer; theranostics

资金

  1. National Institute of Health [1R21CA133641, R01GM094816, P01CA098912, S10RR026399-01]
  2. NATIONAL CANCER INSTITUTE [P01CA098912, R21CA133641] Funding Source: NIH RePORTER
  3. NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026399] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094816] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Theranostic applications require coupling of diagnosis and therapy, a high degree of specificity and adaptability to delivery methods compatible with clinical practice. The tunable physical and biological effects of selective targeting and activation of plasmonic nanobubbles (PNB) were studied in a heterogeneous biological microenvironment of prostate cancer and stromal cells. All cells were targeted with conjugates of gold nanoparticles (NPs) through an anti-body-receptor-endocytosis-nanocluster mechanism that produced NP clusters. The simultaneous pulsed optical activation of intracellular NP clusters at several wavelengths resulted in higher optical contrast and therapeutic selectivity of PNBs compared with those of gold NPs alone. The developed mechanism was termed rainbow plasmonic nanobubbles. The cellular effect of rainbow PNBs was tuned in situ in target cells, thus supporting a theranostic algorithm of prostate cancer cell detection and follow-up guided destruction without damage to collateral cells. The specificity and tunability of PNBs is promising for theranostic applications and we discuss a fiber optic platform that will capitalize on these features to bring theranostic tools to the clinic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据